249 related articles for article (PubMed ID: 21471142)
1. Bone-marrow plasma cell burden correlates with IgM paraprotein concentration in Waldenstrom macroglobulinaemia.
Pasricha SR; Juneja SK; Westerman DA; Came NA
J Clin Pathol; 2011 Jun; 64(6):520-3. PubMed ID: 21471142
[TBL] [Abstract][Full Text] [Related]
2. A Rare Case of Waldenström Macroglobulinemia/Lymphoplasmacytic Lymphoma with Light Chain Discrepancy between B Lymphocyte Population and Serum Paraprotein.
Kim HJ; Hur M; Kim H; Moon HW; Yun YM; Kim SY; Lee MH
Ann Clin Lab Sci; 2015; 45(5):593-7. PubMed ID: 26586715
[TBL] [Abstract][Full Text] [Related]
3. Immunoglobulin M concentration in Waldenström macroglobulinemia: correlation with bone marrow B cells and plasma cells.
de Tute RM; Rawstron AC; Owen RG
Clin Lymphoma Myeloma Leuk; 2013 Apr; 13(2):211-3. PubMed ID: 23523273
[TBL] [Abstract][Full Text] [Related]
4. IgM monoclonal gammopathy/Waldenström's macroglobulinemia: a morphological and immunophenotypic study of the bone marrow.
Feiner HD; Rizk CC; Finfer MD; Bannan M; Gottesman SR; Chuba JV; Amorosi E
Mod Pathol; 1990 May; 3(3):348-56. PubMed ID: 2114024
[TBL] [Abstract][Full Text] [Related]
5. Immunophenotypic analysis of Waldenstrom's macroglobulinemia.
San Miguel JF; Vidriales MB; Ocio E; Mateo G; Sánchez-Guijo F; Sánchez ML; Escribano L; Bárez A; Moro MJ; Hernández J; Aguilera C; Cuello R; García-Frade J; López R; Portero J; Orfao A
Semin Oncol; 2003 Apr; 30(2):187-95. PubMed ID: 12720134
[TBL] [Abstract][Full Text] [Related]
6. Lymphoplasmacytic Lymphoma With a Non-IgM Paraprotein Shows Clinical and Pathologic Heterogeneity and May Harbor MYD88 L265P Mutations.
King RL; Gonsalves WI; Ansell SM; Greipp PT; Frederick LA; Viswanatha DS; He R; Kyle RA; Gertz MA; Kapoor P; Morice WG; Howard MT
Am J Clin Pathol; 2016 Jun; 145(6):843-51. PubMed ID: 27329639
[TBL] [Abstract][Full Text] [Related]
7. Waldenström macroglobulinaemia.
Fonseca R; Hayman S
Br J Haematol; 2007 Sep; 138(6):700-20. PubMed ID: 17672883
[TBL] [Abstract][Full Text] [Related]
8. Waldenström macroglobulinemia: a review of the entity and its differential diagnosis.
Shaheen SP; Talwalkar SS; Lin P; Medeiros LJ
Adv Anat Pathol; 2012 Jan; 19(1):11-27. PubMed ID: 22156831
[TBL] [Abstract][Full Text] [Related]
9. Novel immunophenotypic features of marrow lymphoplasmacytic lymphoma and correlation with Waldenström's macroglobulinemia.
Morice WG; Chen D; Kurtin PJ; Hanson CA; McPhail ED
Mod Pathol; 2009 Jun; 22(6):807-16. PubMed ID: 19287458
[TBL] [Abstract][Full Text] [Related]
10. Role of plasma cells in Waldenström macroglobulinaemia.
El-Ayoubi A; Wang JQ; Hein N; Talaulikar D
Pathology; 2017 Jun; 49(4):337-345. PubMed ID: 28483372
[TBL] [Abstract][Full Text] [Related]
11. MALT lymphoma with IgM paraprotein and bone marrow involvement mimicking Waldenström macroglobulinaemia.
Wang SC; Huang WT; Ma MC; Medeiros LJ; Chang KC
Pathology; 2019 Aug; 51(5):549-553. PubMed ID: 31202483
[No Abstract] [Full Text] [Related]
12. Residual monotypic plasma cells in patients with waldenstrom macroglobulinemia after therapy.
Barakat FH; Medeiros LJ; Wei EX; Konoplev S; Lin P; Jorgensen JL
Am J Clin Pathol; 2011 Mar; 135(3):365-73. PubMed ID: 21350089
[TBL] [Abstract][Full Text] [Related]
13. Waldenström macroglobulinemia with an IgM-kappa antiepidermal basement membrane zone antibody.
Cobb MW; Domloge-Hultsch N; Frame JN; Yancey KB
Arch Dermatol; 1992 Mar; 128(3):372-6. PubMed ID: 1550370
[TBL] [Abstract][Full Text] [Related]
14. Nuclear protein dysregulation in lymphoplasmacytic lymphoma/waldenstrom macroglobulinemia.
Roberts MJ; Chadburn A; Ma S; Hyjek E; Peterson LC
Am J Clin Pathol; 2013 Feb; 139(2):210-9. PubMed ID: 23355206
[TBL] [Abstract][Full Text] [Related]
15. Prognostic validation of the international classification of immunoglobulin M gammopathies: a survival advantage for patients with immunoglobulin M monoclonal gammopathy of undetermined significance?
Gobbi PG; Baldini L; Broglia C; Goldaniga M; Comelli M; Morel P; Morra E; Cortelazzo S; Bettini R; Merlini G
Clin Cancer Res; 2005 Mar; 11(5):1786-90. PubMed ID: 15756000
[TBL] [Abstract][Full Text] [Related]
16. Despite apparent morphologic and immunophenotypic heterogeneity, Waldenstrom's macroglobulinemia is consistently composed of cells along a morphologic continuum of small lymphocytes, plasmacytoid lymphocytes, and plasma cells.
Remstein ED; Hanson CA; Kyle RA; Hodnefield JM; Kurtin PJ
Semin Oncol; 2003 Apr; 30(2):182-6. PubMed ID: 12720133
[TBL] [Abstract][Full Text] [Related]
17. Concomitant Waldenstrom macroglobulinemia and IgA plasmablastic myeloma in a patient with untreated IgM paraproteinemia: sequential development of biclonal B-cell neoplasms over a 10-year period in a single individual.
Wang E; Kulbacki E; Stoecker M
Hum Pathol; 2012 Jul; 43(7):1135-41. PubMed ID: 22404949
[TBL] [Abstract][Full Text] [Related]
18. A case of 'acute' Waldenström macroglobulinaemia.
Malý J; Tichý M; Bláha M; Siroký O; Vanásek J; Jebavý L; Hrncír Z
Haematologia (Budap); 1984; 17(1):125-30. PubMed ID: 6427068
[TBL] [Abstract][Full Text] [Related]
19. Lymphoid neoplasms associated with IgM paraprotein: a study of 382 patients.
Lin P; Hao S; Handy BC; Bueso-Ramos CE; Medeiros LJ
Am J Clin Pathol; 2005 Feb; 123(2):200-5. PubMed ID: 15842043
[TBL] [Abstract][Full Text] [Related]
20. Clinicopathological definition of Waldenstrom's macroglobulinemia: consensus panel recommendations from the Second International Workshop on Waldenstrom's Macroglobulinemia.
Owen RG; Treon SP; Al-Katib A; Fonseca R; Greipp PR; McMaster ML; Morra E; Pangalis GA; San Miguel JF; Branagan AR; Dimopoulos MA
Semin Oncol; 2003 Apr; 30(2):110-5. PubMed ID: 12720118
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]